uniQure N.V.
uniQure N.V.
Insider Sentiment (TTM):
Last Purchase:-Last Sale:2026-06-26Shares Purchased (TTM):0Shares Sold (TTM):632,469
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:55,864,311Shares Outstanding:62,742,847Institutional Ownership Pct.:89.04%
Earnings Market Reaction:
Filing Date:2026-05-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 140 | 80 | 597 | 254 | 217 | 159 | 252 | 288 | 243 | 241 | 229 | 514 | |||||
Debt Securities Held To Maturity Amortized Cost Af… | 447 | 542 | 97 | 123 | 192 | 209 | 184 | 237 | 313 | 377 | 429 | 115 | |||||
Inventory Net | - | - | - | - | - | - | - | - | 8 | 12 | 16 | 10 | |||||
Accounts Receivable Net Current | 4 | - | - | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense Current | 17 | 21 | 10 | 19 | 13 | 9 | 19 | 18 | 19 | 15 | 15 | 12 | |||||
Assets Of Disposal Group Including Discontinued Op… | - | - | - | - | - | - | - | 38 | - | - | - | - | |||||
Assets Current | 616 | 656 | 716 | 409 | 435 | 390 | 464 | 592 | 596 | 652 | 694 | 757 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment Net | 12 | 14 | 15 | 17 | 18 | 20 | 26 | 26 | 45 | 47 | 46 | 49 | |||||
Other Investments | - | - | 30 | 30 | 28 | 27 | 28 | - | - | 2 | - | - | |||||
Other Long Term Investments | 30 | 30 | - | - | - | 27 | - | - | - | - | - | - | |||||
Operating Lease Right Of Use Asset | 12 | 13 | 13 | 14 | 13 | 14 | 15 | 15 | 28 | 29 | 30 | 31 | |||||
Intangible Assets Net Excluding Goodwill | 70 | 73 | 74 | 76 | 72 | 71 | 77 | 59 | 59 | 60 | 58 | 60 | |||||
Goodwill | 25 | 25 | 25 | 25 | 23 | 22 | 24 | 23 | 26 | 26 | 25 | 26 | |||||
Deferred Income Tax Assets Net | 8 | 9 | 9 | 9 | 9 | 10 | 11 | 11 | 12 | 12 | 12 | 14 | |||||
Other Assets Noncurrent | 6 | 6 | 5 | 5 | 5 | 1 | 1 | 5 | 5 | 3 | 6 | 6 | |||||
Assets Noncurrent | 163 | 169 | 172 | 176 | 170 | 166 | 182 | 139 | 174 | 180 | 178 | 186 | |||||
Assets | 779 | 825 | 888 | 585 | 605 | 557 | 646 | 731 | 770 | 832 | 872 | 943 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 4 | 5 | 6 | 6 | 5 | 7 | 5 | 4 | 5 | 7 | 6 | 9 | |||||
Accrued Liabilities Current | 43 | 41 | 52 | 31 | 27 | 29 | 32 | 26 | 23 | 31 | 28 | 24 | |||||
Accrued Income Taxes Current | - | - | 8 | - | - | - | - | - | - | - | - | - | |||||
Business Combination Contingent Consideration Liab… | - | 0 | - | - | - | 0 | 29 | 28 | 28 | 28 | 27 | 28 | |||||
Operating Lease Liability Current | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 8 | 8 | 8 | |||||
Liabilities Current | 59 | 63 | 101 | 41 | 36 | 40 | 71 | 80 | 63 | 74 | 69 | 68 | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities Of Disposal Group Including Discontinu… | - | - | - | - | - | - | - | 18 | - | - | - | - | |||||
Long Term Debt Noncurrent | 50 | 50 | 52 | 52 | 52 | 51 | 51 | 103 | 102 | 102 | 101 | 101 | |||||
Operating Lease Liability Noncurrent | 10 | 10 | 10 | 11 | 11 | 11 | 12 | 12 | 27 | 28 | 29 | 30 | |||||
Business Combination Contingent Consideration Liab… | 17 | 19 | 18 | 16 | 13 | 11 | 12 | 12 | 15 | 15 | 14 | 10 | |||||
Deferred Income Tax Liabilities Net | 8 | 8 | 8 | 8 | 7 | 7 | 8 | 7 | 7 | 8 | 5 | 7 | |||||
Other Liabilities Noncurrent | 3 | 4 | 6 | 6 | 6 | 8 | 9 | 3 | 3 | 4 | 1 | 1 | |||||
Liabilities Noncurrent | 570 | 563 | 559 | 548 | 535 | 523 | 519 | 553 | 560 | 550 | 534 | 521 | |||||
Liabilities | 629 | 626 | 660 | 589 | 572 | 563 | 590 | 634 | 623 | 624 | 603 | 589 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Additional Paid In Capital | 1,588 | 1,582 | 1,576 | 1,263 | 1,258 | 1,173 | 1,166 | 1,163 | 1,156 | 1,149 | 1,142 | 1,131 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -60 | -58 | -59 | -59 | -54 | -53 | -57 | -56 | -56 | -54 | -59 | -52 | |||||
Retained Earnings Accumulated Deficit | -1,382 | -1,329 | -1,292 | -1,211 | -1,174 | -1,130 | -1,057 | -1,012 | -956 | -890 | -817 | -728 | |||||
Stockholders Equity | 149 | 199 | 229 | -4 | 34 | -7 | 56 | 97 | 147 | 208 | 269 | 353 | |||||
Liabilities And Stockholders Equity | 779 | 825 | 888 | 585 | 605 | 557 | 646 | 731 | 770 | 832 | 872 | 943 | |||||
In Process Research And Development | - | - | 0 | 5 | 58 | - | 2 | -0 | 58 | - | -2 | 0 | |||||
Accumulated Depreciation Depletion And Amortizatio… | - | - | 44 | 41 | 36 | - | 31 | 28 | 58 | - | 52 | 49 | |||||
Common Stock Par Or Stated Value Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Common Stock Shares Authorized | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | |||||
Common Stock Shares Issued | 63 | 62 | 62 | 55 | 55 | 49 | 49 | 49 | 48 | 48 | 48 | 48 | |||||
Shares Outstanding | 63 | 62 | 62 | 55 | 55 | 49 | 49 | 49 | 48 | 48 | 48 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 34.83% | 124.53% | 84.17% | - | - | - | - | - | - | - | - | - |
| 2025 | 13.14% | 8.37% | 18.14% | 14.77% | 1.39% | 323.98% | -18.43% | -10.55% | -13.12% | 40.67% | 71.71% | 130.38% |
| 2024 | 2.70% | -7.05% | 72.93% | -17.25% | -28.34% | -14.17% | -1.49% | 188.78% | 158.58% | 13.50% | 7.71% | 13.50% |
| 2023 | -7.99% | -47.41% | -54.75% | -19.30% | -33.24% | -41.81% | 3.70% | -1.67% | -15.32% | -21.08% | -30.19% | -25.11% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 10.40 | 10.43 | 7.12 | 9.98 | 11.99 | 9.74 | 6.51 | 7.36 | 9.39 | 8.85 | 10.11 | 11.07 | |||||
| Quick Ratio | 10.12 | 10.10 | 7.01 | 9.53 | 11.62 | 9.51 | 6.24 | 7.13 | 8.97 | 8.48 | 9.67 | 10.74 | |||||
| Working Capital | 556.55M | 593.07M | 615.56M | 367.64M | 399.11M | 350.24M | 392.87M | 511.50M | 532.53M | 578.18M | 625.02M | 688.60M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 4.21 | 3.15 | 2.88 | -147.11 | 16.97 | -83.43 | 10.57 | 6.53 | 4.25 | 3.00 | 2.24 | 1.67 | |||||
| Interest Coverage TTM | -3.15 | -2.99 | -2.89 | -2.72 | -2.70 | -2.89 | -3.10 | -3.81 | -4.86 | -6.81 | -6.65 | -10.19 | |||||
| Debt Ratio | 0.81 | 0.76 | 0.74 | 1.01 | 0.94 | 1.01 | 0.91 | 0.87 | 0.81 | 0.75 | 0.69 | 0.63 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | 0.15 | 0.14 | |||||
| Days Sales Outstanding TTM | 71.86 | - | - | - | - | - | - | - | - | - | - | - | |||||
| Receivables Turnover TTM | 5.08 | - | - | - | - | - | - | - | - | - | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.33 | -3.46 | -4.02 | -3.63 | -4.10 | -4.92 | -4.92 | -5.86 | -6.14 | -6.47 | -4.78 | -3.92 | |||||
| Free Cash Flow Per Share TTM | -2.75 | -3.10 | -2.63 | -3.18 | -3.15 | -3.83 | -3.79 | -2.27 | -2.80 | -3.21 | -3.38 | -5.28 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 109.44% | 110.47% | 111.87% | 112.11% | 106.50% | 104.67% | 157.23% | 213.83% | 300.73% | 362.31% | 126.16% | 115.09% | |||||
| Operating Profit Margin TTM | -1,059.74% | -1,151.38% | -1,143.16% | -1,180.53% | -838.56% | -679.58% | -700.37% | -872.93% | -1,383.61% | -1,785.46% | -173.93% | -153.89% | |||||
| Net Profit Margin TTM | -1,154.42% | -1,236.00% | -1,492.90% | -1,387.98% | -1,077.05% | -883.35% | -837.80% | -1,027.52% | -1,562.22% | -1,947.09% | -204.17% | -166.83% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -10.44% | -40.64% | -44.90% | -48.25% | 6.30% | 71.17% | -74.45% | -75.25% | -82.73% | -85.12% | 82.16% | 80.64% | |||||
| Net Income Growth (1Y) | -4.00% | -16.94% | -1.82% | -30.10% | -26.71% | -22.34% | 4.83% | 52.45% | 88.68% | 143.30% | 82.21% | 63.73% | |||||
| EPS Growth (1Y) | -18.74% | -29.73% | -18.26% | -37.99% | -33.23% | -23.90% | 2.79% | 49.40% | 84.98% | 138.52% | 78.40% | 60.36% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -4.91 | -6.92 | -14.53 | -3.84 | -2.59 | -3.59 | -1.00 | -0.77 | -0.85 | -1.05 | -1.40 | -2.92 | |||||
| P/B TTM | 6.87 | 6.92 | 14.93 | -190.86 | 16.71 | -127.24 | 4.30 | 2.24 | 1.71 | 1.55 | 1.19 | 1.55 | |||||
| P/S TTM | 56.70 | 85.48 | 216.85 | 53.29 | 27.87 | 31.68 | 8.40 | 7.86 | 13.24 | 20.37 | 2.86 | 4.88 | |||||
| Market Cap | 1.03B | 1.38B | 3.42B | 764.02M | 562.97M | 859.14M | 240.18M | 217.83M | 251.60M | 322.73M | 320.54M | 546.06M | |||||
| Enterprise Value | 934.25M | 1.34B | 2.87B | 560.59M | 397.34M | 750.14M | 38.22M | 29.30M | 107.49M | 179.94M | 189.33M | 130.40M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -172.69M | -178.53M | -153.73M | -174.24M | -167.40M | -186.10M | -184.79M | -110.60M | -135.36M | -153.08M | -161.25M | -251.44M | |||||
| Net Debt | -91.59M | -32.10M | -546.67M | -203.43M | -165.64M | -109.01M | -201.97M | -188.53M | -144.11M | -142.80M | -131.21M | -415.66M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2026-06-26Sale
Owner: Abi-Saab, Walid
Title: Chief Medical Officer
Shares: 1,434
Price/Share: $46.86
Value: $67,197.24
Shares Owned: 168,235
Relationship: Officer
Ownership: Direct
2026-06-25Sale
Owner: Kapusta, Matthew C
Title: CEO, Managing Director
Shares: 28,716
Price/Share: $50.02
Value: $1,436,374.32
Shares Owned: 519,227
Relationship: Director,Officer
Ownership: Direct
2026-06-18Sale
Owner: Kapusta, Matthew C
Title: CEO, Managing Director
Shares: 41,671
Price/Share: $50.00
Value: $2,083,550.00
Shares Owned: 521,795
Relationship: Director,Officer
Ownership: Direct
2026-06-17Sale
Owner: Kaye, Jack
Title: -
Shares: 5,295
Price/Share: $42.57
Value: $225,408.15
Shares Owned: 25,996
Relationship: Director
Ownership: Direct
2026-06-17Sale
Owner: Balachandran, Madhavan
Title: -
Shares: 11,685
Price/Share: $44.45
Value: $519,398.25
Shares Owned: 43,254
Relationship: Director
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
89.04%
Inst. Shares: 55,864,311
Shares Outstanding: 62,742,847
2025-12-31
106.02%
Inst. Shares: 60,964,495
Shares Outstanding: 57,502,068
2025-09-30
92.38%
Inst. Shares: 54,058,044
Shares Outstanding: 58,516,415
2025-06-30
95.95%
Inst. Shares: 52,586,476
Shares Outstanding: 54,807,967
2025-03-31
92.34%
Inst. Shares: 49,042,515
Shares Outstanding: 53,110,580
uniQure N.V. (QURE) — SEC Financial Statements & Analysis
uniQure N.V. (QURE) is a pharmaceutical preparations company. uniQure N.V. trades on Nasdaq as: QURE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), uniQure N.V. reported a -10.44% year-over-year revenue growth, a Gross Profit Margin of 109.44% (TTM), a Debt-to-Equity ratio of 4.21x, a Price-to-Sales (P/S) ratio of 56.70x (TTM), a Price-to-Book (P/B) ratio of 6.87x (TTM), at a market cap of $1.03B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -10.44%
- Gross Profit Margin TTM
- 109.44%
- Debt To Equity
- 4.21x
- P/S TTM
- 56.70x
- P/B TTM
- 6.87x
- Market Cap
- $1.03B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is uniQure N.V. in?
uniQure N.V. (QURE) operates in the Pharmaceutical Preparations industry.
What is QURE's market cap?
uniQure N.V. (QURE) has a market capitalization of $1.03B as of 2026-03-31.
What exchange does QURE trade on?
uniQure N.V. (QURE) trades on the Nasdaq.